These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study.
    Author: Al-Sarraf M, Thigpen T, Groppe CW, Haut A, Padilla F.
    Journal: Cancer Treat Rep; 1978 Jul; 62(7):1101-3. PubMed ID: 356973.
    Abstract:
    Piperazinedione was administered in doses of 9 or 12 mg/m2 by iv infusion every 3 weeks in 28 patients with previously treated malignant melanoma. Of the 25 evaluable patients, 72% had drug-induced toxicity: 40% had leukopenia, 56% had thrombocytopenia, 40% had anemia, and 16% had nausea and vomiting. None of these patients had partial remission, two had stable disease, and the remaining 23 had definite progression of their disease in spite of adequate trial with this agent.
    [Abstract] [Full Text] [Related] [New Search]